Skip to main content
Top
Published in: BMC Health Services Research 1/2020

Open Access 01-12-2020 | Research article

Factors associated with health service orientation and active product marketing orientation in Finnish community pharmacies: a nationwide study among private pharmacy owners

Authors: Lenita Jokinen, Inka Puumalainen, Marja Airaksinen

Published in: BMC Health Services Research | Issue 1/2020

Login to get access

Abstract

Background

Little is known about pharmacy owners’ commitment to public health and health policy goals in the strategic planning of their business. The aim of this study was to explore factors associated with health service orientation and active product marketing orientation of Finnish community pharmacy owners.

Methods

A national cross-sectional e-mail survey was sent to private community pharmacy owners in Finland (n = 581) in 2013. Based on the structured, Likert-type survey instrument, two sum scales measuring strategic orientation towards health service provision (13 items, score range 0–26) and active product marketing (8 items, score range 0–16) were developed (Cronbach’s Alpha 0.836 and 0.699, respectively). Characteristics of the pharmacy owners and their pharmacy business as well as actual service provision were used as background variables.

Results

Concerning health service orientation, 50% of the respondents received at least 20 points out of the maximum 26 points (score range: 0–26). For active product marketing orientation, 75% of the pharmacy owners had at least 14 points and 44% received full 16 points (score range: 0–16). The score distribution was skewed towards strong health service orientation, but the actual service score was heavily skewed towards few services or no services. Two-thirds of the pharmacy owners reported having available 2 or less services. The health service orientation was not influenced by any of the background variables used, but three of them influenced active product marketing orientation, namely business location, annual prescription volume and belonging to a marketing chain of individual community pharmacies.

Conclusion

Large pharmacies located close to rivals and belonging to marketing chains of individual community pharmacies differentiated as those having a high product marketing orientation. The health service orientation was not influenced by any of the explanatory variables used in this study. The discrepancy between high health service orientation scores and low actual service provision scores needs further investigation. The contradiction that exists between pharmaceutical policy goals and the generation of income of pharmacies should also be examined as a contributing factor in this respect.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roberts A, Benrimoj S, Chen T, Williams K, Hopp T, Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Soc Admin Pharm. 2005;1(4):546–64.CrossRef Roberts A, Benrimoj S, Chen T, Williams K, Hopp T, Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Soc Admin Pharm. 2005;1(4):546–64.CrossRef
2.
go back to reference Stubbings J, Nutescu E, Durley SF, Bauman JL. Payment for clinical pharmacy services revisited. Pharmacotherapy. 2011;31(1):1–8.CrossRef Stubbings J, Nutescu E, Durley SF, Bauman JL. Payment for clinical pharmacy services revisited. Pharmacotherapy. 2011;31(1):1–8.CrossRef
4.
go back to reference Wisell K. The liberalization experiment. Understanding the political rationales leading to change in pharmacy policy. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy; 2019. Wisell K. The liberalization experiment. Understanding the political rationales leading to change in pharmacy policy. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy; 2019.
5.
go back to reference Bulajeva A, Labberton L, Leikola S, Pohjanoksa-Mäntylä M, Geurts MM, de Gier JJ, Airaksinen M. Medication review practices in European countries. Res Social Adm Pharm. 2014;10(5):731–40.CrossRef Bulajeva A, Labberton L, Leikola S, Pohjanoksa-Mäntylä M, Geurts MM, de Gier JJ, Airaksinen M. Medication review practices in European countries. Res Social Adm Pharm. 2014;10(5):731–40.CrossRef
6.
go back to reference Reinikainen L, Lämsä E, Happonen P, Hämeen-Anttila K. Finnish Medicines Agency Fimea. Deregulation of the pharmacy system in Europe – actions and effects: Serial Publication Fimea Develops, Assesses and Informs 3/2017. ISBN 978-952-5624-75-5. Reinikainen L, Lämsä E, Happonen P, Hämeen-Anttila K. Finnish Medicines Agency Fimea. Deregulation of the pharmacy system in Europe – actions and effects: Serial Publication Fimea Develops, Assesses and Informs 3/2017. ISBN 978-952-5624-75-5.
11.
go back to reference Benrimoj SI, Frommer MS. Community pharmacy in Australia. Aust Health Rev. 2004;28(2):238–46.CrossRef Benrimoj SI, Frommer MS. Community pharmacy in Australia. Aust Health Rev. 2004;28(2):238–46.CrossRef
12.
go back to reference Ym M, Mossialos E, Huseyin N, Courtin E. Expanding the role of community pharmacists: Policymaking in the absence of policy-relevant evidence? Health Pol. 2013;111:135–48.CrossRef Ym M, Mossialos E, Huseyin N, Courtin E. Expanding the role of community pharmacists: Policymaking in the absence of policy-relevant evidence? Health Pol. 2013;111:135–48.CrossRef
15.
go back to reference Ministry of Social Affairs and Health. Apteekkitoiminnan ja muun lääkehuollon kehittäminen. Final report. Reports and Memorandums 2015:4, [in Finnish] Helsinki 2015. Ministry of Social Affairs and Health. Apteekkitoiminnan ja muun lääkehuollon kehittäminen. Final report. Reports and Memorandums 2015:4, [in Finnish] Helsinki 2015.
16.
go back to reference Ministry of Social Affairs and Health. Lääkekorvausjärjestelmän kehittäminen. Lääkekorvausjärjestelmän kehittämistyöryhmän loppuraportti, STM:n julkaisu, [in Finnish] Helsinki 2013. Ministry of Social Affairs and Health. Lääkekorvausjärjestelmän kehittäminen. Lääkekorvausjärjestelmän kehittämistyöryhmän loppuraportti, STM:n julkaisu, [in Finnish] Helsinki 2013.
17.
go back to reference Association of Finnish Pharmacies. The strategy and strategy goals 2012–2020. [in Finnish] Helsinki 2011. Association of Finnish Pharmacies. The strategy and strategy goals 2012–2020. [in Finnish] Helsinki 2011.
18.
go back to reference Jokinen L, Puumalainen I, Airaksinen M. Influence of strategic planning on product marketing and health service orientation of community pharmacies - a national survey in Finland. Health Policy. 2019;123:462–7.CrossRef Jokinen L, Puumalainen I, Airaksinen M. Influence of strategic planning on product marketing and health service orientation of community pharmacies - a national survey in Finland. Health Policy. 2019;123:462–7.CrossRef
19.
go back to reference Imfeld-Isenegger T, Soares IB, Makovec UN. Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration. Res Social Adm Pharm. 2020;16(8):1057–66.CrossRef Imfeld-Isenegger T, Soares IB, Makovec UN. Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration. Res Social Adm Pharm. 2020;16(8):1057–66.CrossRef
20.
go back to reference Dawoud D, Haines A, Wonderling D, Ashe J, Hill J, Varia M, Dyer P, Bion J. Cost effectiveness of advanced pharmacy services provided in the community and primary care settings: a systematic review. Pharmacoeconomics. 2019;37(10):1241–60.CrossRef Dawoud D, Haines A, Wonderling D, Ashe J, Hill J, Varia M, Dyer P, Bion J. Cost effectiveness of advanced pharmacy services provided in the community and primary care settings: a systematic review. Pharmacoeconomics. 2019;37(10):1241–60.CrossRef
21.
go back to reference Houle S, Carter C, Tsuyuki R, Grinrod K. Remunerated patient care services and injectons by pharmacist: an international update; 2019. Houle S, Carter C, Tsuyuki R, Grinrod K. Remunerated patient care services and injectons by pharmacist: an international update; 2019.
22.
go back to reference Vogler S, Habimana K, Arts D. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs?Evidence from nine European countries. Health Pol. 2014;117:311–27.CrossRef Vogler S, Habimana K, Arts D. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs?Evidence from nine European countries. Health Pol. 2014;117:311–27.CrossRef
23.
go back to reference Ministry of Social Affairs and Health. Rational Pharmacotherapy Action Plan. Reports and Memorandums of the Ministry of Social Affairs and Health, vol. 12; 2018. Ministry of Social Affairs and Health. Rational Pharmacotherapy Action Plan. Reports and Memorandums of the Ministry of Social Affairs and Health, vol. 12; 2018.
24.
go back to reference Toivo T, Dimitrow M, Puustinen J, Savela E, Pelkonen K, Kiuru V, Suominen T, Kinnunen S, Uunimäki M, Kivelä SL, Leikola S, Airaksinen M. Coordinating resources for prospective medication risk management of older home care clients in primary care: procedure development and RCT study design for demonstrating its effectiveness. BMC Geriatr. 2018;18(1):74.CrossRef Toivo T, Dimitrow M, Puustinen J, Savela E, Pelkonen K, Kiuru V, Suominen T, Kinnunen S, Uunimäki M, Kivelä SL, Leikola S, Airaksinen M. Coordinating resources for prospective medication risk management of older home care clients in primary care: procedure development and RCT study design for demonstrating its effectiveness. BMC Geriatr. 2018;18(1):74.CrossRef
25.
go back to reference Kallio S, Kiiski A, Airaksinen M, Mäntylä A, Kumpusalo-Vauhkonen A, Järvensivu T, Pohjanoksa-Mäntylä M. Community Pharmacists' contribution to medication reviews for older adults: a systematic review. J Am Geriatr Soc. 2018;66(8):1613–20.CrossRef Kallio S, Kiiski A, Airaksinen M, Mäntylä A, Kumpusalo-Vauhkonen A, Järvensivu T, Pohjanoksa-Mäntylä M. Community Pharmacists' contribution to medication reviews for older adults: a systematic review. J Am Geriatr Soc. 2018;66(8):1613–20.CrossRef
26.
go back to reference Kallio S, Kumpusalo-Vauhkonen A, Järvensivu T, Mäntylä A, Pohjanoksa-Mäntylä M, Airaksinen M. Towards interprofessional networking in medication management of the aged: current challenges and potential solutions in Finland. Scand J Prim Health Care. 2016;34:368–76.CrossRef Kallio S, Kumpusalo-Vauhkonen A, Järvensivu T, Mäntylä A, Pohjanoksa-Mäntylä M, Airaksinen M. Towards interprofessional networking in medication management of the aged: current challenges and potential solutions in Finland. Scand J Prim Health Care. 2016;34:368–76.CrossRef
27.
go back to reference White L, Klinner C. Service quality in community pharmacy: an exploration of determinants. Res Soc Admin Pharm. 2012;8(2):122–32.CrossRef White L, Klinner C. Service quality in community pharmacy: an exploration of determinants. Res Soc Admin Pharm. 2012;8(2):122–32.CrossRef
28.
go back to reference Eades C, Ferguson J, O'Carroll R. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health. 2011;11(1):582–95.CrossRef Eades C, Ferguson J, O'Carroll R. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health. 2011;11(1):582–95.CrossRef
29.
go back to reference Puumalainen I. Development of instruments to measure the quality of patient counselling. Doctoral dissertation. University of Kuopio: Kuopio University Publications A. Pharmaceutical Sciences 83; 2005. Puumalainen I. Development of instruments to measure the quality of patient counselling. Doctoral dissertation. University of Kuopio: Kuopio University Publications A. Pharmaceutical Sciences 83; 2005.
30.
go back to reference Westerling A. Information technology development needs in community pharmacies. A Strategic Approach. Väitöskirja. Helsingin yliopisto, 2011. Westerling A. Information technology development needs in community pharmacies. A Strategic Approach. Väitöskirja. Helsingin yliopisto, 2011.
31.
go back to reference Kurko T. Deregulation of nicotine replacement therapy products in Finland: reasons for pharmaceutical policy changes and reflections on smoking cessation practices. Doctoral dissertation, University of Helsinki 2015. http://urn.fi/URN:ISBN:978-951-51-1223-1. Accessed Jan 13, 2019. Kurko T. Deregulation of nicotine replacement therapy products in Finland: reasons for pharmaceutical policy changes and reflections on smoking cessation practices. Doctoral dissertation, University of Helsinki 2015. http://​urn.​fi/​URN:​ISBN:​978-951-51-1223-1. Accessed Jan 13, 2019.
32.
go back to reference Ministry of Social Affairs and Health. Avohuollon apteekkitoiminnan kehittämistarpeet. Sosiaali- ja terveysministeriön selvityksiä 2011:16, [in Finnish]. Helsinki Finland 2011. Ministry of Social Affairs and Health. Avohuollon apteekkitoiminnan kehittämistarpeet. Sosiaali- ja terveysministeriön selvityksiä 2011:16, [in Finnish]. Helsinki Finland 2011.
33.
go back to reference Sinnemäki J, Sihvo S, Isojärvi J, Blom M, Airaksinen M, Mäntylä A. Automated dose dispensing service for primary healthcare patients: a systematic review. Syst Rev. 2013;2:1.CrossRef Sinnemäki J, Sihvo S, Isojärvi J, Blom M, Airaksinen M, Mäntylä A. Automated dose dispensing service for primary healthcare patients: a systematic review. Syst Rev. 2013;2:1.CrossRef
Metadata
Title
Factors associated with health service orientation and active product marketing orientation in Finnish community pharmacies: a nationwide study among private pharmacy owners
Authors
Lenita Jokinen
Inka Puumalainen
Marja Airaksinen
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2020
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-020-05469-y

Other articles of this Issue 1/2020

BMC Health Services Research 1/2020 Go to the issue